Cellink Ab Stock Performance
| CLLKF Stock | USD 3.65 0.33 8.29% |
On a scale of 0 to 100, Cellink AB holds a performance score of 7. The firm shows a Beta (market volatility) of 0.17, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Cellink AB's returns are expected to increase less than the market. However, during the bear market, the loss of holding Cellink AB is expected to be smaller as well. Please check Cellink AB's total risk alpha, expected short fall, period momentum indicator, as well as the relationship between the value at risk and rate of daily change , to make a quick decision on whether Cellink AB's price patterns will revert.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Cellink AB are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile forward-looking signals, Cellink AB reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 808.7 M | |
| Total Cashflows From Investing Activities | -4.5 B | |
| Free Cash Flow | -676.2 M |
Cellink |
Cellink AB Relative Risk vs. Return Landscape
If you would invest 301.00 in Cellink AB on December 2, 2024 and sell it today you would earn a total of 64.00 from holding Cellink AB or generate 21.26% return on investment over 90 days. Cellink AB is currently producing 0.3873% returns and takes up 4.186% volatility of returns over 90 trading days. Put another way, 37% of traded pink sheets are less volatile than Cellink, and 93% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Cellink AB Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cellink AB's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Cellink AB, and traders can use it to determine the average amount a Cellink AB's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0925
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CLLKF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.19 actual daily | 37 63% of assets are more volatile |
Expected Return
| 0.39 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average Cellink AB is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cellink AB by adding it to a well-diversified portfolio.
Cellink AB Fundamentals Growth
Cellink Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Cellink AB, and Cellink AB fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cellink Pink Sheet performance.
| Return On Equity | 0.0068 | |||
| Return On Asset | -0.025 | |||
| Profit Margin | 0.02 % | |||
| Current Valuation | 973.88 M | |||
| Shares Outstanding | 69.07 M | |||
| Price To Book | 1.23 X | |||
| Price To Sales | 4.61 X | |||
| Revenue | 1.26 B | |||
| EBITDA | 37.7 M | |||
| Total Debt | 1.35 B | |||
| Debt To Equity | 0.26 % | |||
| Cash Flow From Operations | (409.2 M) | |||
| Earnings Per Share | 0.06 X | |||
| Total Asset | 9.75 B | |||
About Cellink AB Performance
By analyzing Cellink AB's fundamental ratios, stakeholders can gain valuable insights into Cellink AB's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Cellink AB has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Cellink AB has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
BICO Group AB operates as a bio convergence company in North America, Europe, Asia, and internationally. BICO Group AB was founded in 2016 and is based in Gothenburg, Sweden. Bico Group is traded on OTC Exchange in the United States.Things to note about Cellink AB performance evaluation
Checking the ongoing alerts about Cellink AB for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Cellink AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cellink AB had very high historical volatility over the last 90 days | |
| Cellink AB has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 1.26 B. Net Loss for the year was (227.6 M) with profit before overhead, payroll, taxes, and interest of 1.03 B. | |
| Cellink AB generates negative cash flow from operations | |
| About 39.0% of the company shares are held by company insiders |
- Analyzing Cellink AB's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cellink AB's stock is overvalued or undervalued compared to its peers.
- Examining Cellink AB's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cellink AB's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cellink AB's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cellink AB's pink sheet. These opinions can provide insight into Cellink AB's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Cellink Pink Sheet analysis
When running Cellink AB's price analysis, check to measure Cellink AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellink AB is operating at the current time. Most of Cellink AB's value examination focuses on studying past and present price action to predict the probability of Cellink AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellink AB's price. Additionally, you may evaluate how the addition of Cellink AB to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |